Management of advanced stages of Osteonecrosis of the Jaws due to Bisphosphonates: Report of two cases
Keywords:Bisphosphonates, Multiple myeloma, Breast cancer, Osteonecrosis, Jaws
Bisphosphonates are a class of drugs used to strengthen bone. They are indicated in the treatment of osteoporosis and Paget's disease as well as malignant pathologies such as breast cancer, bone metastases. The examples of medications bisphosphonates includes Aledronate, Ibandronate, Incadronate, Olpadronate, Pamidronate, Risedronate, and Zoledronate. One of the most important complications of bisphosphonates is osteonecrosis of the jaws which alters the quality of life of the patient and is all the more difficult to manage as osteonecrosis is advanced. This paper describes two cases of advanced osteonecrosis whose management was very difficult leading to a recurrence of this complication.
How to Cite
Asian Pacific Journal of Health Sciences applies the Creative Commons Attribution (CC-BY) license to published articles. Under this license, authors retain ownership of the copyright for their content, but they allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. Appropriate attribution can be provided by simply citing the original article.